More articles from Letters to the editor

You have access
Severe hyponatremia: Are you monitoring the urine output?
Anup Katyal, MD and Ashwani Joshi, MD

Cleveland Clinic Journal of Medicine July 2024, 91 (7) 397; DOI: https://doi.org/10.3949/ccjm.91c.07001
You have access
When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
Aditya Sharma, MD, MHPE, FRCPC

Cleveland Clinic Journal of Medicine April 2024, 91 (4) 207; DOI: https://doi.org/10.3949/ccjm.91c.04001
You have access
In Reply: When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
Osamah Z. Badwan, MD, Venu Menon, MD and W. H. Wilson Tang, MD

Cleveland Clinic Journal of Medicine April 2024, 91 (4) 207-208; DOI: https://doi.org/10.3949/ccjm.91c.04002
You have access
2023 Update in ambulatory general internal medicine
Ashley Lim

Cleveland Clinic Journal of Medicine March 2024, 91 (3) 145-146; DOI: https://doi.org/10.3949/ccjm.91c.03001
You have access
In Reply: 2023 Update in ambulatory general internal medicine
Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD

Cleveland Clinic Journal of Medicine March 2024, 91 (3) 146; DOI: https://doi.org/10.3949/ccjm.91c.03002
You have access
In Reply: Surgical and procedural management of benign prostatic hyperplasia
Ayodeji E. Sotimehin, MD and Bradley C. Gill, MD, MS

Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83-84; DOI: https://doi.org/10.3949/ccjm.91c.02004
You have access
Surgical and procedural management of benign prostatic hyperplasia
Sameer Gadani, MD, Ihab Haddadin, MD, Justin Guan, MD, Michael Bergen, MD and Abraham Levitin, MD

Cleveland Clinic Journal of Medicine February 2024, 91 (2) 83; DOI: https://doi.org/10.3949/ccjm.91c.02003
You have access
In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
Pooja Prasad, MD and Megha Prasad, MD

Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82-83; DOI: https://doi.org/10.3949/ccjm.91c.02002
You have access
Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
Taher Modarressi, MD

Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82; DOI: https://doi.org/10.3949/ccjm.91c.02001
You have access
A new paradigm for adult ADHD
Vania Modesto-Lowe, MD, MPH and Samantha Frigon

Cleveland Clinic Journal of Medicine October 2023, 90 (10) 592; DOI: https://doi.org/10.3949/ccjm.90c.10001

Main menu

User menu

Search

More articles from Letters to the editor

Pages

Navigate

Authors & Reviewers